Aquestive Therapeutics (AQST) Change in Inventory (2017 - 2026)

Aquestive Therapeutics' Change in Inventory history runs 10 years deep, the most recent figure standing at $1.9 million for Q1 2026.

• On a quarterly basis, Change in Inventory rose 64.3% year-over-year to $1.9 million in Q1 2026; TTM through Mar 2026 was $868000.0, a 261.94% increase from a year earlier, with the FY2025 full-year figure at $126000.0, up 117.38% from the prior year.
• Change in Inventory advanced to $1.9 million in Q1 2026 per AQST's latest filing, from -$1.7 million in the prior quarter.
• Across five years, Change in Inventory topped out at $1.9 million in Q1 2026 and bottomed at -$1.7 million in Q4 2025.
• The 5-year median for Change in Inventory is $379000.0 (2022), against an average of $237000.0.
• Across the five-year window, Change in Inventory jumped 7054.17% in 2022 and slumped 538.18% in 2025, its largest moves.
• Year by year, Change in Inventory stood at -$944000.0 in 2022, then soared by 67.16% to -$310000.0 in 2023, then tumbled by 215.16% to -$977000.0 in 2024, then tumbled by 75.44% to -$1.7 million in 2025, then surged by 210.62% to $1.9 million in 2026.
• Per Business Quant, the three latest AQST Change in Inventory figures stand at $1.9 million (Q1 2026), -$1.7 million (Q4 2025), and -$241000.0 (Q3 2025).